Skip to main content
Top

Supportive Care in Cancer

Issue 5/1998

Content (13 Articles)

SUPPORTIVE CARE INTERNATIONAL

Palliative care in Italy: the current situation

A. Sbanotto, Ruth Burnhill

SPECIAL ARTICLE

Cancer pain management in developing countries: a mosaic of complex issues resulting in inadequate analgesia

Rachel C. Koshy, Deborah Rhodes, Saraswathi Devi, S. A. Grossman

REVIEW ARTICLE

Empiric therapy for the febrile neutropenic patient

Stephen C. Schimpff

ORIGINAL ARTICLE

Effect of carboplatin on response and palliation in hormone-refractory prostate cancer

W. F. Jungi, Jürg Bernhard, Christoph Hürny, Shu-Fang Hsu Schmitz, Silvia Hanselmann, Heidi Gusset, Dietegen Pestalozzi, Aron Goldhirsch

ORIGINAL ARTICLE

Tetanus immunity in patients with hematological malignancies

V. Hamarström, K. Pauksen, H. Svensson, G. Öberg, C. Paul, P. Ljungman

SHORT COMMUNICATION

Competent gastrostomy for patients with head and neck cancer

P. P. Vassilopoulos, E. Filopoulos, N. Kelessis, M. Gontikakis, G. Plataniotis

ORIGINAL ARTICLE

Rationale for the use of a single fixed intravenous dolasetron dose for the prevention of cisplatin-induced nausea and vomiting

J. B. Whitmore, Mark G. Kris, Paul J. Hesketh, Thomas H. Grote, Dawn M. DuBois, Michael B. Cramer, William F. Hahne

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine